Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002090172-25-000001
Filing Date
2025-10-06
Accepted
2025-10-06 16:22:50
Documents
2
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1537
2 POA taylorboyd.txt EX-24 4074
  Complete submission text file 0002090172-25-000001.txt   7184
Mailing Address C/O AVALO THERAPEUTICS, INC. 1500 LIBERTY RIDGE DRIVE, SUITE 321 WAYNE PA 19087
Business Address